# Amphastar (AMPH) — News

AMPH · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/amph/news

## Recent headlines

- [Banca Monte Dei Paschi di Siena SPA: ISP has made continuation of ISP offer conditional upon abandonment of MPS project](https://www.ainvest.com/news/banca-monte-dei-paschi-di-siena-spa-isp-continuation-isp-offer-conditional-abandonment-mps-project-2610) — AInvest Wire, Oct 12, 2026
  Banca Monte dei Paschi di Siena S.p.A. (BMPS), one of Italy’s largest and oldest financial institutions, has recently encountered a development in its strategic initiatives. An Internet Service Provider (ISP) has made the continuation of its offer conditional upon the abandonment of a project…
- [Wh Smith PLC: Panmure Liberum initiates coverage with buy rating; target price 420p](https://www.ainvest.com/news/wh-smith-plc-panmure-liberum-initiates-coverage-buy-rating-target-price-420p-2610) — AInvest Wire, Oct 12, 2026
  Panmure Liberum has initiated coverage on WH Smith PLC (SMWH), assigning the stock a "buy" rating and setting a target price of 420p per share. The firm's decision follows a comprehensive analysis of the company’s market position, operational performance, and growth potential. While no recent price…
- [Bio-pharmaceutical stocks fell in regular trading, with Eton Pharmaceuticals down 3.3%, Livent down 5.0% and BioTelemetry down 6.2%.](https://www.ainvest.com/news/bio-pharmaceutical-stocks-fell-regular-trading-eton-pharmaceuticals-3-3-livent-5-0-biotelemetry-6-2-2609) — AInvest Wire, Sep 30, 2026
  On September 30, 2026, bio-pharmaceutical stocks experienced declines in regular trading, with several companies posting notable losses. Eton Pharmaceuticals fell 3.3%, Livent dropped 5.0%, and BioTelemetry declined by 6.2%. The sector has faced ongoing scrutiny due to stretched valuations and…
- [Amphastar 2Q adj EPS 91c, est. 62c](https://www.ainvest.com/news/amphastar-2q-eps-91c-est-62c-2608) — AInvest Wire, Aug 6, 2026
- [Amphastar Pharmaceuticals - on July 2nd, co's unit receives FDA warning letter for South El Monte facility - SEC filing](https://www.ainvest.com/news/amphastar-pharmaceuticals-july-2nd-unit-receives-fda-warning-letter-south-el-monte-facility-sec-filing-2607) — AInvest Wire, Jul 8, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).